Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

Add Yahoo as a preferred source to see more of our stories on Google. PCR testing soared during the pandemic as the go-to, drive-through, quick-turnaround way to discover if you had COVID. The genie ...

Labcorp is adding to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging. The line includes the company’s Plasma Detect ID, a whole exome sequence-guided, ...

A Shenzhen University team has created a light-driven blood sensor that detects cancer-related microRNAs with high specificity, offering potential for early diagnosis.

“Neoadjuvant treatment with 12 weeks of THP led to a pCR rate of 64% in patients with early-stage HER2-positive, ER-negative breast cancer at the time of surgery, compared to 33% for those with ...

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer that may remain in the body after treatment and can signal a higher risk of ...

Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...